EQSAdhoc QIAGEN NV Key word Share Buyback QIAGEN NV QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase 07Jan2024 1903 CETCEST Disclosure of an inside inf
EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Venlo, the Netherlands, Jan. 07, 2024 QIAGEN N.V. today announced a plan to return up to approximately $300 million to shareholders through a synthetic share repurchase that combines a direct.
QIAGEN Expands Presence in Middle East with New Riyadh HQ, MoU with Saudi Ministry of Health, and Oman TB Screening Initiative news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.